Fixed-dose combination drugs: Innovative formulation and development strategies for bringing best-in-class products to market

Whitepaper

Fixed dose combination drugs (FDCs) have become an important alternative to monotherapy in the treatment of many diseases and conditions, including hypertension, diabetes, cancer, tuberculosis, asthma and COPD, and they hold promise for many more. Our tools can accurately identify effective combinations for many drugs on the market and help avoid those that may be problematic. By identifying potentially effective combinations or indications, our digital analytics can expedite time to market for novel therapies, benefitting patients and patent holders.